Sensitivity to Cisplatin in Head and Neck Cancer Cells Is Significantly Affected by Patient-Derived Cancer-Associated Fibroblasts
Abstract
:1. Introduction
2. Results
2.1. Clinical Characterization of Patients and Tumors Used for CAFs Preparation
2.2. Lineage Specificity of Patient-Derived CAFs and Preparation of Conditioned Media
2.3. Patient-Derived CAFs Affect the Colony-Forming Capability of Cancer Cells
2.4. The Colony-Forming Capability of FaDu Cells after CAF Coculture Is Related to Cancer-Associated Genes
2.5. Cisplatin Response in FaDu Cells Is CAF-Specific
2.6. Platin Amount Accumulated to and Released from CAFs Relates to Aggressiveness
3. Discussion
4. Materials and Methods
4.1. Model Cell Lines
4.2. Tumor Samples Collection
4.3. Patient-Derived Cell Cultures
4.4. Colony-Forming Assay
4.5. Gene Expression Analysis
4.6. RNA Isolation and Reverse Transcription
4.7. Quantitative Real-Time Polymerase Chain Reaction
4.8. Cisplatin Concentration in CAF-Derived Media
4.9. Statistical Analysis
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Lemaire, F.; Millon, R.; Young, J.; Cromer, A.; Wasylyk, C.; Schultz, I.; Muller, D.; Marchal, P.; Zhao, C.; Melle, D.; et al. Differential expression profiling of head and neck squamous cell carcinoma (HNSCC). Br. J. Cancer 2003, 89, 1940–1949. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hutchinson, L. Drug therapy: Cetuximab or cisplatin in HNSCC? Nat. Rev. Clin. Oncol. 2016, 13, 66. [Google Scholar] [CrossRef]
- Nishimura, K.; Tsuchiya, Y.; Okamoto, H.; Ijichi, K.; Gosho, M.; Fukayama, M.; Yoshikawa, K.; Ueda, H.; Bradford, C.R.; Carey, T.E.; et al. Identification of chemoresistant factors by protein expression analysis with iTRAQ for head and neck carcinoma. Br. J. Cancer 2014, 111, 799–806. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Castells, M.; Thibault, B.; Delord, J.P.; Couderc, B. Implication of tumor microenvironment in chemoresistance: Tumor-associated stromal cells protect tumor cells from cell death. Int. J. Mol. Sci. 2012, 13, 9545–9571. [Google Scholar] [CrossRef] [PubMed]
- Meads, M.B.; Gatenby, R.A.; Dalton, W.S. Environment-mediated drug resistance: A major contributor to minimal residual disease. Nat. Rev. Cancer 2009, 9, 665–674. [Google Scholar] [CrossRef]
- Plzak, J.; Lacina, L.; Chovanec, M.; Dvorankova, B.; Szabo, P.; Cada, Z.; Smetana, K., Jr. Epithelial-stromal interaction in squamous cell epithelium-derived tumors: An important new player in the control of tumor biological properties. Anticancer Res. 2010, 30, 455–462. [Google Scholar]
- Lacina, L.; Plzak, J.; Kodet, O.; Szabo, P.; Chovanec, M.; Dvorankova, B.; Smetana, K., Jr. Cancer microenvironment: What can we learn from the stem cell niche. Int. J. Mol. Sci. 2015, 16, 24094–24110. [Google Scholar] [CrossRef]
- Schliekelman, M.J.; Creighton, C.J.; Baird, B.N.; Chen, Y.; Banerjee, P.; Bota-Rabassedas, N.; Ahn, Y.H.; Roybal, J.D.; Chen, F.; Zhang, Y.; et al. Thy-1(+) cancer-associated fibroblasts adversely impact lung cancer prognosis. Sci. Rep. 2017, 7, 6478. [Google Scholar] [CrossRef]
- Gao, J.; Zhao, S.; Halstensen, T.S. Increased interleukin-6 expression is associated with poor prognosis and acquired cisplatin resistance in head and neck squamous cell carcinoma. Oncol. Rep. 2016, 35, 3265–3274. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Liu, T.; Han, C.; Wang, S.; Fang, P.; Ma, Z.; Xu, L.; Yin, R. Cancer-associated fibroblasts: An emerging target of anti-cancer immunotherapy. J. Hematol. Oncol. 2019, 12, 86. [Google Scholar] [CrossRef]
- Che, Y.; Wang, J.; Li, Y.; Lu, Z.; Huang, J.; Sun, S.; Mao, S.; Lei, Y.; Zang, R.; Sun, N.; et al. Cisplatin-activated PAI-1 secretion in the cancer-associated fibroblasts with paracrine effects promoting esophageal squamous cell carcinoma progression and causing chemoresistance. Cell Death Dis. 2018, 9, 759. [Google Scholar] [CrossRef] [Green Version]
- Rollins, B.J.; Sunday, M.E. Suppression of tumor formation in vivo by expression of the JE gene in malignant cells. Mol. Cell Biol. 1991, 11, 3125–3131. [Google Scholar] [CrossRef] [Green Version]
- Walter, S.; Bottazzi, B.; Govoni, D.; Colotta, F.; Mantovani, A. Macrophage infiltration and growth of sarcoma clones expressing different amounts of monocyte chemotactic protein/JE. Int. J. Cancer 1991, 49, 431–435. [Google Scholar] [CrossRef] [PubMed]
- Conti, I.; Rollins, B.J. CCL2 (monocyte chemoattractant protein-1) and cancer. Semin. Cancer Biol. 2004, 14, 149–154. [Google Scholar] [CrossRef] [PubMed]
- Lin, T.Y.; Chan, H.H.; Chen, S.H.; Sarvagalla, S.; Chen, P.S.; Coumar, M.S.; Cheng, S.M.; Chang, Y.C.; Lin, C.H.; Leung, E.; et al. BIRC5/Survivin is a novel ATG12-ATG5 conjugate interactor and an autophagy-induced DNA damage suppressor in human cancer and mouse embryonic fibroblast cells. Autophagy 2020, 16, 1296–1313. [Google Scholar] [CrossRef] [Green Version]
- Ren, J.H.; He, W.S.; Nong, L.; Zhu, Q.Y.; Hu, K.; Zhang, R.G.; Huang, L.L.; Zhu, F.; Wu, G. Acquired cisplatin resistance in human lung adenocarcinoma cells is associated with enhanced autophagy. Cancer Biother. Radiopharm 2010, 25, 75–80. [Google Scholar] [CrossRef] [PubMed]
- Liao, J.K.; Zhou, B.; Zhuang, X.M.; Zhuang, P.L.; Zhang, D.M.; Chen, W.L. Cancer-associated fibroblasts confer cisplatin resistance of tongue cancer via autophagy activation. Biomed. Pharmacother. 2018, 97, 1341–1348. [Google Scholar] [CrossRef] [PubMed]
- Tao, L.; Huang, G.; Wang, R.; Pan, Y.; He, Z.; Chu, X.; Song, H.; Chen, L.-B. Cancer-associated fibroblasts treated with cisplatin facilitates chemoresistance of lung adenocarcinoma through IL-11/IL-11R/STAT3 signaling pathway. Sci. Rep. 2016, 6, 38408. [Google Scholar] [CrossRef]
- Keysar, S.B.; Le, P.N.; Miller, B.; Jackson, B.C.; Eagles, J.R.; Nieto, C.; Kim, J.; Tang, B.; Glogowska, M.J.; Morton, J.J.; et al. Regulation of head and neck squamous cancer stem cells by PI3K and SOX2. JNCI 2016, 109, djw189. [Google Scholar] [CrossRef]
- Wirtz, E.D.; Hoshino, D.; Maldonado, A.T.; Tyson, D.R.; Weaver, A.M. Response of head and neck squamous cell carcinoma cells carrying PIK3CA mutations to selected targeted therapies. JAMA Otolaryngol. Head Neck Surg. 2015, 141, 543–549. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Yang, Z.; Liao, J.; Carter-Cooper, B.A.; Lapidus, R.G.; Cullen, K.J.; Dan, H. Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ETS-1 signaling pathway. BMC Cancer 2019, 19, 485. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Eisenberg, E.; Levanon, E.Y. Human housekeeping genes, revisited. Trends Genet. 2013, 29, 569–574. [Google Scholar] [CrossRef] [PubMed]
- R Core Team. R: A Language and Environment for Statistical Computing; R Foundation for Statistical Computing: Vienna, Austria; Available online: https://www.R-project.org/ (accessed on 9 February 2021).
- Wickham, H. ggplot2: Elegant Graphics for Data Analysis; Springer: New York, NY, USA, 2016. [Google Scholar]
- Warnes, G.R.; Bolker, B.; Bonebakker, L.; Gentleman, R.; Huber, W.; Liaw, A.; Lumley, T.; Maechler, M.; Magnusson, A.; Moeller, S.; et al. gplots: Various R Programming Tools for Plotting Data. R Package Version 2.17.0. Available online: https://www.scienceopen.com/document?vid=0e5d8e31-1fe4-492f-a3d8-8cd71b2b8ad9 (accessed on 9 February 2021).
- Day, A. Heatmap.Plus: Heatmap with More Sensible Behavior. Available online: https://CRAN.R-project.org/package=heatmap.plus (accessed on 9 February 2021).
- Wei, T.; Simko, V. R Package “Corrplot”: Visualization of a Correlation Matrix. Available online: https://github.com/taiyun/corrplot (accessed on 9 February 2021).
- Kassambara, A. ggpubr: ‘ggplot2’ Based Publication Ready Plots. Available online: https://CRAN.R-project.org/package=ggpubr (accessed on 9 February 2021).
- Rohart, F.; Gautier, B.; Singh, A.; Le, C.K.-A. mixOmics: An R package for ‘omics feature selection and multiple data integration. PLoS Comput. Biol. 2017, 13, e1005752. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Patient | Gender | Age at Diagnosis | Tumor Location | pT | pN | cM | G | p16 | Stage | Surgery + Adjuvant Radiotherapy | Adjuvant Chemotherapy | Recurrence |
---|---|---|---|---|---|---|---|---|---|---|---|---|
M5.1 | F | 59 | larynx | 4a | 2b | 0 | 3 | 0 | IVA | 1 | 0 | 0 |
M6.1 | M | 81 | oropharynx | 2 | 0 | 0 | 2 | 0 | I | 1 | 0 | 0 |
M7.1 | M | 60 | hypopharynx | 2 | 2b | 0 | 2 | 1 | IVA | 1 | 0 | 1 |
M9.1 | M | 54 | oropharynx | 2 | 1 | 0 | 2 | 1 | I | 1 | 1 | 1 |
M11.1 | M | 63 | oropharynx | 2 | 2 | 0 | 3 | 1 | II | 1 | 1 | 0 |
M12.1 | M | 49 | larynx | 4a | 1 | 0 | 3 | 0 | IVA | 1 | 0 | 0 |
M14.1 | M | 62 | larynx | 4a | 0 | 0 | 2 | 0 | IVA | 1 | 0 | 0 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Peltanova, B.; Liskova, M.; Gumulec, J.; Raudenska, M.; Polanska, H.H.; Vaculovic, T.; Kalfert, D.; Grega, M.; Plzak, J.; Betka, J.; et al. Sensitivity to Cisplatin in Head and Neck Cancer Cells Is Significantly Affected by Patient-Derived Cancer-Associated Fibroblasts. Int. J. Mol. Sci. 2021, 22, 1912. https://doi.org/10.3390/ijms22041912
Peltanova B, Liskova M, Gumulec J, Raudenska M, Polanska HH, Vaculovic T, Kalfert D, Grega M, Plzak J, Betka J, et al. Sensitivity to Cisplatin in Head and Neck Cancer Cells Is Significantly Affected by Patient-Derived Cancer-Associated Fibroblasts. International Journal of Molecular Sciences. 2021; 22(4):1912. https://doi.org/10.3390/ijms22041912
Chicago/Turabian StylePeltanova, Barbora, Marketa Liskova, Jaromir Gumulec, Martina Raudenska, Hana Holcova Polanska, Tomas Vaculovic, David Kalfert, Marek Grega, Jan Plzak, Jan Betka, and et al. 2021. "Sensitivity to Cisplatin in Head and Neck Cancer Cells Is Significantly Affected by Patient-Derived Cancer-Associated Fibroblasts" International Journal of Molecular Sciences 22, no. 4: 1912. https://doi.org/10.3390/ijms22041912
APA StylePeltanova, B., Liskova, M., Gumulec, J., Raudenska, M., Polanska, H. H., Vaculovic, T., Kalfert, D., Grega, M., Plzak, J., Betka, J., & Masarik, M. (2021). Sensitivity to Cisplatin in Head and Neck Cancer Cells Is Significantly Affected by Patient-Derived Cancer-Associated Fibroblasts. International Journal of Molecular Sciences, 22(4), 1912. https://doi.org/10.3390/ijms22041912